Table 1.
Pretreatment Demographic Characteristics
| Baseline Characteristic | Total (n = 251) |
|---|---|
| Age, years | 56.3 ± 8.01 |
| Male, n (%) | 173 (69) |
| Race | |
| Black, n (%) | 201 (80) |
| White, n (%) | 47 (19) |
| Mixed, n (%) | 3 (1) |
| HIV+, n (%) | 79 (31) |
| Diabetes, n (%) | 42 (17) |
| BMI, kg/m2 | 28.6 ± 6.3 |
| Fibrosis stage | |
| F0-1, n (%) | 151 (60) |
| F2-3, n (%) | 73 (29) |
| F4, n (%) | 26 (10) |
| Months follow-up | 28.2 ± 13 |
| HbA1c, % | 5.75 ± 0.82 |
| Glucose, mg/dL | 103.2 ± 32.1 |
| Cholesterol, mg/dL | 161.1 ± 36.1 |
| HDL, mg/dL | 51.9 ± 22.4 |
| LDL, mg/dL | 86.6 ± 31.9 |
| Triglycerides, mg/dL | 122.2 ± 71.7 |
| ALT, U/L | 56.6 ± 37.0 |
| AST, U/L | 66.0 ± 48.7 |
Values are means ± standard deviation, unless noted.
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; HbA1c, hemoglobin A1c; LDL, low-density lipoprotein; HDL, high-density lipoprotein; HIV, human immunodeficiency virus.